LEXX
Price:
$0.5402
Market Cap:
$11.04M
Lexaria Bioscience Corp. is a biotechnology company focused on advanced drug delivery. Its proprietary and patented DehydraTECH technology is designed to significantly improve the oral delivery of active pharmaceutical ingredients, enhancing their absorption into the bloodstream. This innovative platform has shown impressive results, boosting the bioavailability of compounds such as cannabinoids and nicotine by 5 to 10 times, and in some cannabinoid applications, by as much as 27 times, when compared to standard formulations. DehydraTECH also drastically cuts the time of onset from hours to mere minutes and effectively neutralizes unpleasant tastes. Beyond its established uses, the technolog...[Read more]
Industry
Biotechnology
IPO Date
2021-01-12
Stock Exchange
NASDAQ
Ticker
LEXX
According to Lexaria Bioscience Corp.’s latest financial reports and current stock price. The company's current ROE is -190.06%. This represents a change of 257.17% compared to the average of -53.21% of the last 4 quarters.
The mean historical ROE of Lexaria Bioscience Corp. over the last ten years is -193.39%. The current -190.06% ROE has changed -1.72% with respect to the historical average. Over the past ten years (40 quarters), LEXX's ROE was at its highest in in the February 2021 quarter at 3.43%. The ROE was at its lowest in in the May 2016 quarter at -213.79%.
Average
-193.39%
Median
-163.91%
Minimum
-456.60%
Maximum
-30.36%
Discovering the peaks and valleys of Lexaria Bioscience Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 452.04%
Maximum Annual ROE = -30.36%
Minimum Annual Increase = -86.38%
Minimum Annual ROE = -456.60%
| Year | ROE | Change |
|---|---|---|
| 2025 | -398.10% | 452.04% |
| 2024 | -72.11% | -67.06% |
| 2023 | -218.94% | 139.41% |
| 2022 | -91.45% | 201.25% |
| 2021 | -30.36% | -80.51% |
| 2020 | -155.79% | -9.44% |
| 2019 | -172.02% | -37.74% |
| 2018 | -276.31% | 344.38% |
| 2017 | -62.18% | -86.38% |
| 2016 | -456.60% | 99.20% |
The current ROE of Lexaria Bioscience Corp. (LEXX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-229.72%
5-year avg
-162.19%
10-year avg
-193.39%
Lexaria Bioscience Corp.’s ROE is greater than Hoth Therapeutics, Inc. (-165.25%), greater than Allarity Therapeutics, Inc. (-109.94%), greater than Lixte Biotechnology Holdings, Inc. (-125.56%), greater than Entero Therapeutics, Inc. (-18.69%), less than Clearside Biomedical, Inc. (55.47%), greater than Cingulate Inc. (-365.16%), greater than BriaCell Therapeutics Corp. (-147.92%), less than CASI Pharmaceuticals, Inc. (358.32%), greater than Processa Pharmaceuticals, Inc. (-281.30%), less than Curis, Inc. (805.67%),
| Company | ROE | Market cap |
|---|---|---|
| -165.25% | $14.19M | |
| -109.94% | $22.75M | |
| -125.56% | $88.33M | |
| -18.69% | $13.58M | |
| 55.47% | $2.15M | |
| -365.16% | $27.97M | |
| -147.92% | $5.46M | |
| 358.32% | $2.33M | |
| -281.30% | $4.80M | |
| 805.67% | $5.54M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lexaria Bioscience Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Lexaria Bioscience Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Lexaria Bioscience Corp.'s ROE?
How is the ROE calculated for Lexaria Bioscience Corp. (LEXX)?
What is the highest ROE for Lexaria Bioscience Corp. (LEXX)?
What is the 3-year average ROE for Lexaria Bioscience Corp. (LEXX)?
What is the 5-year average ROE for Lexaria Bioscience Corp. (LEXX)?
How does the current ROE for Lexaria Bioscience Corp. (LEXX) compare to its historical average?